UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical guide to fertility preservation in hematopoietic cell transplant recipients

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.477-484

2014

Volltextzugriff (PDF)

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

The American heart journal, 2007, Vol.153 (1), p.66.e9-66.e16

2007

Volltextzugriff (PDF)

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Journal of the American College of Cardiology, 2014-09, Vol.64 (10), p.1005-1014

2014

Volltextzugriff (PDF)

Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently

Clinical pharmacology and therapeutics, 2007-05, Vol.81 (5), p.735-741

2007

Volltextzugriff (PDF)

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Transplant infectious disease, 2019-12, Vol.21 (6), p.e13187-n/a

2019

Volltextzugriff (PDF)

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

European heart journal, 2008, Vol.29 (1), p.21-30

2008

Volltextzugriff (PDF)

In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation

Journal of thrombosis and haemostasis, 2011-03, Vol.9 (3), p.552-561

2011

Volltextzugriff (PDF)

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4996-5010

2010

Volltextzugriff (PDF)

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

European heart journal, 2006-05, Vol.27 (10), p.1166-1173

2006

Volltextzugriff (PDF)

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Journal of the American College of Cardiology, 2013-08, Vol.62 (7), p.577-583

2013

Volltextzugriff (PDF)

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial

European heart journal, 2009-07, Vol.30 (14), p.1753-1763

2009

Volltextzugriff (PDF)

Arrhythmias in the setting of hematopoietic cell transplants

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1212-1216

2015

Volltextzugriff (PDF)

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants

Bone marrow transplantation (Basingstoke), 2013-01, Vol.48 (1), p.99-104

2013

Volltextzugriff (PDF)

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

European heart journal, 2011-04, Vol.32 (7), p.838-846

2011

Volltextzugriff (PDF)

Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation

Leukemia & lymphoma, 2022-06, Vol.63 (7), p.1686-1693

2022

Volltextzugriff (PDF)

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

Journal of the American College of Cardiology, 2012-11, Vol.60 (20), p.2032-2040

2012

Volltextzugriff (PDF)

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update

Journal of clinical oncology, 2008-01, Vol.26 (1), p.132-149

2008

Volltextzugriff (PDF)

A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats

PloS one, 2016-04, Vol.11 (4), p.e0154661-e0154661

2016

Volltextzugriff (PDF)

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function

Thrombosis and haemostasis, 2010-06, Vol.103 (6), p.1210-1217

2010

Volltextzugriff (PDF)

Acute Hyperglycemia Induced by Ketamine/Xylazine Anesthesia in Rats: Mechanisms and Implications for Preclinical Models

Experimental biology and medicine (Maywood, N.J.), 2005-11, Vol.230 (10), p.777-784

2005

Volltextzugriff (PDF)

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

Blood, 2014-02, Vol.123 (8), p.1270-1278

2014

Volltextzugriff (PDF)

Identification of a Robust Five-Gene Risk Model in Prostate Cancer: A Robust Likelihood-Based Survival Analysis

International journal of genomics, 2020, Vol.2020 (2020), p.1-23

2020

Volltextzugriff (PDF)

Whole Genome Sequencing of Greater Amberjack (Seriola dumerili) for SNP Identification on Aligned Scaffolds and Genome Structural Variation Analysis Using Parallel Resequencing

International journal of genomics, 2018-01, Vol.2018 (2018), p.1-12

2018

Volltextzugriff (PDF)

Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo

Journal of the American College of Cardiology, 2008-12, Vol.52 (24), p.1968-1977

2008

Volltextzugriff (PDF)

1 – 25 von 5.571

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.207)
Mit Volltextzugriff
(4.213)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical guide to fertility preservation in hematopoietic cell transplant recipients

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients

Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Arrhythmias in the setting of hematopoietic cell transplants

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update

A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function

Acute Hyperglycemia Induced by Ketamine/Xylazine Anesthesia in Rats: Mechanisms and Implications for Preclinical Models

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation

Identification of a Robust Five-Gene Risk Model in Prostate Cancer: A Robust Likelihood-Based Survival Analysis

Whole Genome Sequencing of Greater Amberjack (Seriola dumerili) for SNP Identification on Aligned Scaffolds and Genome Structural Variation Analysis Using Parallel Resequencing

Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo

Suchergebnisse filtern